JENNIFER YOUNG: Open Payments
NPI 1770849606 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 16 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $221 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $71 |
| Amgen Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
| PFIZER INC. | 1 | $30 |
| Exact Sciences Corporation | 1 | $21 |
Products named: LEQVIO, SPRAVATO, MOUNJARO, COBENFY, REPATHA, ELIQUIS, ZEPBOUND, EVENITY.
Industry payments across CA — which companies pay providers there.
